Company profile
Envista Holdings Corp
NYSE: NVST · Healthcare · Medical - Instruments & Supplies
#96 of 1,422 Healthcare companies by revenue54th-percentile growth
EA Score
73BFH 83DQ 71GM 44SS 73
v0.1 · 65/100 weight · provisional
↑ Piotroski F, workforce scale · ↓ listing tenure, growth stability
Methodology →Revenue TTM
$2.8B
Rev growth YoY (TTM)
+12.1%
Net income (FY)
$47.0M
Employees
12,000
as of 2026-08-07
Market cap
$4.5B
as of 2026-08-07
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$2.7B$2.7B2025
Net income$47.0M$47.0M2025
Operating income$216.1M$216.1M2025
Total assets$5.7B$5.7B2025
Equity$3.1B$3.1B2025
Revenue trend
FY2021 – FY2025 · USD
FY21
FY21
FY21
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Envista Holdings Corp’s revenue?
Envista Holdings Corp booked $2.7B in FY2025 revenue, growing 8.3% year over year — about the middle of the pack among Healthcare companies we track, at a 1.7% net margin.
Peers · Healthcare
AMN Healthcare Services, Inc.70BQuidelOrtho Corporation54DFortrea Holdings Inc.50DInsulet Corp.83B+Bio-Rad Laboratories, Inc.84B+Medpace Holdings, Inc.84B+Neighbors
Orange →Key facts
CEOPaul A. Keel
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersBrea, CA
ExchangeNYSE: NVST
Employees12,000
IPO date2019-09-18
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.